Objectives: Few national surveys have been conducted on the health and nutrition of disabled people in Japan, and as a result, the actual health and nutritional status of this population group has not been clarified. The aim of the present study is to clarify the following hypotheses: nutritional assessment is not carried out at institutions and schools for individuals with intellectual disabilities (ID) and/or motor disabilities (MD), and there are marked differences in implementation rates and assessment methods (i) between institutions and schools and (ii) among the disability categories.

Methods: Questionnaires were sent to 1,080 selected institutions and schools for individuals with ID and/or MD. For each disability category, the implementation rate of blood and urine tests (14 items) was calculated separately for the institutions and schools.

Results: A total of 826 responses were obtained (response rate: 76.5%); of these, 822 were valid. For all investigated items, implementation rate was significantly higher for the institutions (0-90.3%) when compared to the schools (0-10.2%). The implementation rate of 13 items at institutions for patients with severe intellectual and motor disabilities (4.8-90.3%) was higher than that for institutions for those with intellectual disabilities (0.4-57.0%) or institutions for those with motor disabilities (0-80.0%). The implementation rate of creatinine urinary excretion/24 h and creatinine height index was lower than that for other examinations.

Conclusions: Large differences in implementation rates were apparent between the institutions and schools. The implementation rate of blood and urine laboratory examinations varied considerably among the disability categories.

Download full-text PDF

Source
http://dx.doi.org/10.3177/jnsv.53.437DOI Listing

Publication Analysis

Top Keywords

institutions schools
20
implementation rate
20
motor disabilities
16
blood urine
12
schools individuals
12
intellectual disabilities
12
institutions
10
individuals intellectual
8
disabilities and/or
8
and/or motor
8

Similar Publications

Exploring the decisional needs of patients living with subacromial pain syndrome: A qualitative needs assessment study.

Musculoskelet Sci Pract

January 2025

Center for General Practice, Aalborg University, Aalborg, Denmark; Department of Health Science and Technology, Aalborg University, Aalborg, Denmark. Electronic address:

Background: There are a variety of different treatments for patients living with subacromial pain syndrome (SAPS). All treatments have small to moderate effect sizes, and it is challenging when healthcare practitioners and patients need to decide on which treatment options to choose. The aim of this study was to explore and understand the decisional needs of patients with SAPS, to inform and support the decision-making process.

View Article and Find Full Text PDF

Electromyography (EMG) is increasingly used in stroke assessment research, with studies showing that EMG co-contraction (EMG-CC) of upper limb muscles can differentiate stroke patients from healthy individuals and correlates with clinical scales assessing motor function. This suggests that EMG-CC has potential for both assessing motor impairments and monitoring recovery in stroke patients. However, systematic reviews on EMG-CC's effectiveness in stroke assessment are lacking.

View Article and Find Full Text PDF

Objectives: It is estimated that up to 65 % of pwMS (people with multiple sclerosis) experience varying degrees of cognitive impairment, the most commonly affected domain being Information Processing Speed (IPS). As sleep disturbance is a predictor of detriments in IPS, the authors aimed to study the association between the severity of Restless Legs Syndrome (RLS) and Obstructive Sleep Apnea (OSA) symptoms with IPS in pwMS.

Methods: In a cross-sectional study, the authors enrolled people with relapsing-remitting and secondary progressive MS referred to the comprehensive MS center of Kashani Hospital in Isfahan, Iran.

View Article and Find Full Text PDF

Surface receptor-targeted Protein-based nanocarriers for drug delivery: Advances in cancer therapy.

Nanotechnology

January 2025

Department of Biotechnology, Kalasalingam Academy of Research and Education (Deemed to be University), Anand Nagar, School of Bio, Chemical & Process Enginneering, Krishnankoil, Krishnan Kovil, Tamil Nadu, 626126, INDIA.

Significant progress has been made in cancer therapy with protein-based nanocarriers targeted directly to surface receptors for drug delivery. The nanocarriers are a potentially effective solution for the potential drawbacks of traditional chemotherapy, such as lack of specificity, side effects, and development resistance. Peptides as nanocarriers have been designed based on their biocompatible, biodegradable, and versatile functions to deliver therapeutic agents into cancer cells, reduce systemic toxicity, and maximize therapy efficacy through utilizing targeted ligands such as antibodies, amino acids, vitamins, and other small molecules onto protein-based nanocarriers and thus ensuring that drugs selectively accumulate in the cancer cells instead of healthy organs/drug release at a target site without effects on normal cells, which inherently caused less systemic toxicity/off-target effect.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!